February 16, 2024
Prior litigation that referred to Janssen Biotech's marketing practices does not bar a False Claims Act complaint from moving forward because the earlier cases did not allege the same type of fraud, a Massachusetts federal judge ruled Thursday.
May 18, 2023
Lawyers for a whistleblower and Janssen Biotech sparred Thursday over whether three old lawsuits sink their current kickbacks and false claims case, with a Boston federal judge trying to nail down whether the earlier actions put the government on notice of the alleged fraud.
March 15, 2023
In a request for judgment in its favor, Janssen Biotech told a Massachusetts federal judge Tuesday that the False Claims Act kickback allegations filed by a former employee had already been disclosed to the government in previous litigation.
March 10, 2023
Janssen Biotech Inc. must hand over its communications with federal agencies regarding a former employee's claims filed on behalf of the government that the company paid doctors kickbacks to boost its drug sales, a Boston federal judge ordered.
January 03, 2023
Pharmaceutical giant Janssen on Monday attempted to shift blame for delays in a kickback suit to the purported whistleblower who filed the case, saying she was the one hindering discovery and demanding materials that are outside the scope of the Massachusetts federal court's orders.
December 16, 2022
Pharmaceutical giant Janssen is refusing to comply with previous orders for discovery, impeding the progress of a suit alleging that it paid kickbacks to doctors to boost sales of certain drugs, attorneys for a relator told a Massachusetts federal judge Thursday.